uniQure N.V.
Symbol: QURE (NASDAQ)
17.35
▼ (-0.80%) -0.140
Company Description:
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Key Stats
- Today's Open: $17.49
- Today's High: $17.999
- Today's Low: $17.26
- Today's Volume: 821.69K
- Yesterday Close: $17.49
- Yesterday High: $17.76
- Yesterday Low: $17.03
- Yesterday Volume: 819.90K
- Last Min Volume: 30
- Last Min High: $17.35
- Last Min Low: $17.35
- Last Min VWAP: $17.35
Company Profile
- Name: uniQure N.V.
- Website: https://www.uniqure.com
- Listed Date: 2014-02-05
- Location: AMSTERDAM, P7
- Market Status: Active
- CIK Number: 0001590560
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $956.33M
- Round Lot: 100
- Outstanding Shares: 54.87M
- Asset Type: CS
RECENT FILINGS FOR QURE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-07-31 | SCHEDULE 13G | View |
| 2025-07-29 | 8-K | View |
| 2025-07-29 | 424B5 | View |
| 2025-07-29 | 10-Q | View |
| 2025-07-29 | 8-K | View |
| 2025-07-01 | 4 | View |
| 2025-06-30 | S-8 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-13 | 8-K | View |
Latest News on QURE